Back to today’s briefing

Story perspectives

Zurich Launches Precision CancerCare to Aid Employees

4/7/2025

44 3

Summary

Story summary

Zurich Corporate Risk has unveiled Precision CancerCare, a groundbreaking service designed to support clients grappling with cancer, the top cause of claims. This innovative offering features genetic testing, tumor profiling, and second opinions, providing crucial assistance for employees after diagnosis. With cancer-related absences projected to cost UK employers £8.5 billion by 2025, this initiative is timely and essential.

1 of 1

Story summary

Zurich Corporate Risk has unveiled Precision CancerCare, a groundbreaking service designed to support clients grappling with cancer, the top cause of claims. This innovative offering features genetic testing, tumor profiling, and second opinions, providing crucial assistance for employees after diagnosis. With cancer-related absences projected to cost UK employers £8.5 billion by 2025, this initiative is timely and essential.